. 2023; 33(3): 316-321 | DOI: 10.4274/anatoljmed.2022.02679 | ||||
Determination of Confirmation Rate of Anti-HCV Test Pozitivity with HCV-RNAGüneş Şenol1, Meral Coşkun1, Osman Kaftan1, Can Biçmen2, Ayriz Tuba Gündüz2, Mahmut Mete Demirel2, Ferhat Demirci31İzmir Bakırçay University Faculty of Medicine, Çiğli Training and Research Hospital, Clinic of Infectious Diseases and Clinical Microbiology, İzmir, Turkey2University of Health Scienses Turkey, İzmir Chest Diseases and Surgery Hospital, Clinic of Medical Microbiology, İzmir, Turkey 3University of Health Scienses Turkey, İzmir Chest Diseases and Surgery Hospital, Clinic of Medical Biochemistry, İzmir, Turkey Objective: Timely diagnosis of the disease is important to prevent late complications in hepatitis C infection. Anti-hepatitis C virus (HCV) tests are regularly requested in screening test panels. However, it is seen that even seropositive patients cannot be followed appropriately. In this study, it was aimed to reveal the missed opportunities in terms of diagnosis and treatment of HCV infection in the seropositive patient group detected by screening tests. Güneş Şenol, Meral Coşkun, Osman Kaftan, Can Biçmen, Ayriz Tuba Gündüz, Mahmut Mete Demirel, Ferhat Demirci. Determination of Confirmation Rate of Anti-HCV Test Pozitivity with HCV-RNA. . 2023; 33(3): 316-321 Sorumlu Yazar: Güneş Şenol, Türkiye |
|